本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Regulus Therapeutics Inc

7.98
+0.02500.31%
成交量:42.59萬
成交額:337.33萬
市值:5.52億
市盈率:-11.03
高:7.98
開:7.91
低:7.88
收:7.95
資料載入中...
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/17

SEC問詢函

Form CORRESP - Correspondence
2024/03/25

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/21

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/20

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/18

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/02/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/18

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/06

SEC問詢函

Form CORRESP - Correspondence
2023/11/10

重要事件披露

Form 8-K - Current report
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/06/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/23

重要事件披露

Form 8-K - Current report